B

Boryung Corp
KRX:003850

Watchlist Manager
Boryung Corp
KRX:003850
Watchlist
Price: 9 140 KRW -2.14%
Market Cap: 784.1B KRW

Relative Value

The Relative Value of one Boryung Corp stock under the Base Case scenario is 13 598.52 KRW. Compared to the current market price of 9 140 KRW, Boryung Corp is Undervalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
13 598.52 KRW
Undervaluation 33%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
75
Median 3Y
0.8
Median 5Y
0.8
Industry
2.6
Forward
0.7
vs History
15
vs Industry
37
Median 3Y
14.9
Median 5Y
18.7
Industry
21.6
Forward
13.6
vs History
68
vs Industry
38
Median 3Y
10.6
Median 5Y
13.1
Industry
16.5
vs History
50
vs Industry
7
Median 3Y
4.3
Median 5Y
6
Industry
22.5
vs History
84
vs Industry
61
Median 3Y
1.1
Median 5Y
1.3
Industry
2.3
vs History
71
vs Industry
78
Median 3Y
0.9
Median 5Y
0.9
Industry
2.9
Forward
0.8
vs History
44
vs Industry
70
Median 3Y
2.3
Median 5Y
2.4
Industry
5.5
vs History
47
vs Industry
42
Median 3Y
7.4
Median 5Y
7.6
Industry
13
Forward
7.3
vs History
61
vs Industry
36
Median 3Y
12.2
Median 5Y
12.7
Industry
16.6
Forward
11.3
vs History
66
vs Industry
40
Median 3Y
11.6
Median 5Y
15.8
Industry
15.8
vs History
34
vs Industry
29
Median 3Y
16.1
Median 5Y
14.9
Industry
19.1
vs History
76
vs Industry
63
Median 3Y
0.9
Median 5Y
1
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Boryung Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Boryung Corp
KRX:003850
772.2B KRW 0.8 24.3 7.6 12.1
US
Eli Lilly and Co
NYSE:LLY
1T USD 16.8 54.3 36.5 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
504B USD 5.5 20.1 16.4 21.3
CH
Roche Holding AG
SIX:ROG
252.4B CHF 4.1 26.8 11.5 13.4
UK
AstraZeneca PLC
LSE:AZN
210.7B GBP 4.8 30 108 158
CH
Novartis AG
SIX:NOVN
206.8B CHF 4.6 18.1 11.5 14.8
US
Merck & Co Inc
NYSE:MRK
245.9B USD 3.8 12.9 9.2 10.9
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.3 13.1 9.2 10.7
IE
Endo International PLC
LSE:0Y5F
209B USD 90.1 -71.5 331.1 830.4
US
Pfizer Inc
NYSE:PFE
143B USD 2.3 14.6 7.4 10.1
P/E Multiple
Earnings Growth PEG
KR
B
Boryung Corp
KRX:003850
Average P/E: 23.8
24.3
-1%
N/A
US
Eli Lilly and Co
NYSE:LLY
54.3
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20.1
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.9
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.1
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.6
29%
0.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
B
Boryung Corp
KRX:003850
Average EV/EBITDA: 399.5
7.6
3%
2.5
US
Eli Lilly and Co
NYSE:LLY
36.5
33%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.4
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.5
4%
2.9
UK
AstraZeneca PLC
LSE:AZN
108
10%
10.8
CH
Novartis AG
SIX:NOVN
11.5
6%
1.9
US
Merck & Co Inc
NYSE:MRK
9.2
6%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
9.2
2%
4.6
IE
E
Endo International PLC
LSE:0Y5F
331.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
1%
7.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
B
Boryung Corp
KRX:003850
Average EV/EBIT: 1 711.2
12.1
8%
1.5
US
Eli Lilly and Co
NYSE:LLY
39.1
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158
23%
6.9
CH
Novartis AG
SIX:NOVN
14.8
12%
1.2
US
Merck & Co Inc
NYSE:MRK
10.9
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
10.7
1%
10.7
IE
E
Endo International PLC
LSE:0Y5F
830.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.1
8%
1.3